| Obesity in Children |
1 |
1 |
| Obesity |
0 |
0.9 |
| Adolescent Medicine |
0 |
0.98 |
| Child |
0 |
0.56 |
| Child and Adolescent Psychiatry |
0 |
0.48 |
| GLP-1 Receptor Agonist |
0 |
0.97 |
| Depression |
0 |
0.8 |
| Type 2 Diabetes Mellitus |
0 |
0.3 |
| Receptors |
0 |
0.28 |
| Mood Disorders |
0 |
0.14 |
| Neurotransmitters |
0 |
0.14 |
| Suicide |
0 |
0.99 |
| Weight Loss |
0 |
0.14 |
| Otolaryngology |
0 |
0.13 |
| Upper Respiratory Tract Infection |
0 |
0.1 |
| Social Determinants of Health |
0 |
0.09 |
| Weight Management |
0 |
0.09 |
| Antidepressant drug |
0 |
0.07 |
| Body Mass Index |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Imbalance |
0 |
0.07 |
| Mental Illness |
0 |
0.07 |
| Meta-Analysis |
0 |
0.07 |
| Neuroinflammation |
0 |
0.07 |
| New York |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |
| Respiratory Tract |
0 |
0.07 |
| Socioeconomics |
0 |
0.07 |